Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137202 · ClinicalTrials.gov registry record · NA
Post Burn Pruritus Study in Patients Undergoing Wound Healing
A NA study of Itching, sponsored by United States Army Institute of Surgical Research.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT00137202 is a NA study of Itching that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00137202, a NA study of Itching, has completed, sponsored by United States Army Institute of Surgical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if a drug called ondansetron (Zofran) controls itching from healing burn wounds as well or better than the usual drug used, diphenhydramine (Benadryl).
Conditions Studied
Interventions
- DRUG Ondansetron (Zofran)
- DRUG Diphenhydramine (Benadryl)
Study Locations (1)
Texas
- US Army Institute of Surgical Research - Fort Sam Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00137202
The ClinicalTrials.gov registry entry for NCT00137202 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Institute of Surgical Research, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Itching appearing as the primary indexed condition, and to 2 interventions - of which Ondansetron (Zofran) is the first listed.
NCT00137202 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00137202 about?
NCT00137202 is a clinical study titled "Post Burn Pruritus Study in Patients Undergoing Wound Healing". The purpose of this study is to see if a drug called ondansetron (Zofran) controls itching from healing burn wounds as well or better than the usual drug used, diphenhydramine (Benadryl).
What is the current status of trial NCT00137202?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2005-06. Estimated completion is 2006-05.
What conditions does trial NCT00137202 study?
This clinical trial studies the following conditions: Itching.
What interventions are being tested in trial NCT00137202?
The interventions under investigation include: Ondansetron (Zofran) (DRUG), Diphenhydramine (Benadryl) (DRUG).
Who is sponsoring clinical trial NCT00137202?
This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00137202 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Itching
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.